Literature DB >> 12490001

Development of catheter-based procedures for transducing the isolated rabbit liver with plasmid DNA.

Simon J Eastman1, Kevin M Baskin, Bradley L Hodges, Qiuming Chu, Amy Gates, Rebecca Dreusicke, Scott Anderson, Ronald K Scheule.   

Abstract

Rapid systemic injection of naked plasmid DNA (pDNA) in a large volume into a mouse tail vein has been shown to result in a high level of gene expression in the liver. However, the potential therapeutic benefit to humans embodied in hydrodynamic transfection of the liver cannot be realized until a clinically viable method for gene delivery is developed. In light of this fact, we have devised and evaluated several methods for delivering pDNA to the isolated rabbit liver using minimally invasive catheter-based techniques. Using a lobar technique, pDNA was delivered hydrodynamically to an isolated hepatic lobe using a balloon occlusion balloon catheter to occlude a selected hepatic vein. A whole organ technique was used wherein the entire hepatic venous system was isolated and the pDNA solution injected hydrodynamically into the vena cava between two balloons used to block hepatic venous outflow. Lobar delivery of a plasmid encoding a secreted alkaline phosphatase (SEAP) reporter gene resulted in significant levels of transgene product in the serum. A nonsecreted transgene product, chloramphenicol acetyltransferase (CAT), showed the highest levels of expression in the injected lobe distal to the injection site. Compared to lobar delivery, whole organ delivery yielded much higher serum levels of SEAP expression and a significantly broader hepatic parenchymal distribution of CAT expression. These preliminary studies suggest that catheter-mediated hydrodynamic delivery of pDNA to the isolated liver may provide a method for human gene therapy that is both therapeutically significant and clinically practicable.

Entities:  

Mesh:

Year:  2002        PMID: 12490001     DOI: 10.1089/10430340260395910

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  43 in total

1.  Hydroporation as the mechanism of hydrodynamic delivery.

Authors:  G Zhang; X Gao; Y K Song; R Vollmer; D B Stolz; J Z Gasiorowski; D A Dean; D Liu
Journal:  Gene Ther       Date:  2004-04       Impact factor: 5.250

Review 2.  Liver-directed gene therapy for dyslipidemia and diabetes.

Authors:  Kazuhiro Oka; Lawrence Chan
Journal:  Curr Atheroscler Rep       Date:  2004-05       Impact factor: 5.113

Review 3.  Gene therapy for liver regeneration: experimental studies and prospects for clinical trials.

Authors:  Hussein-M Atta
Journal:  World J Gastroenterol       Date:  2010-08-28       Impact factor: 5.742

4.  Gene transfer: how can the biological barriers be overcome?

Authors:  Jean-Michel Escoffre; Justin Teissié; Marie-Pierre Rols
Journal:  J Membr Biol       Date:  2010-07-10       Impact factor: 1.843

Review 5.  Nonviral gene delivery: what we know and what is next.

Authors:  Xiang Gao; Keun-Sik Kim; Dexi Liu
Journal:  AAPS J       Date:  2007-03-23       Impact factor: 4.009

Review 6.  RNAi therapeutics: principles, prospects and challenges.

Authors:  Lars Aagaard; John J Rossi
Journal:  Adv Drug Deliv Rev       Date:  2007-03-16       Impact factor: 15.470

7.  Prolongation of heart allograft survival after long-term expression of soluble MHC class I antigens and vIL-10 in the liver by AAV-plasmid-mediated gene transfer.

Authors:  A Doenecke; E Frank; M N Scherer; H-J Schlitt; E K Geissler
Journal:  Langenbecks Arch Surg       Date:  2008-03-06       Impact factor: 3.445

8.  RNA interference: A futuristic tool and its therapeutic applications.

Authors:  Anghesom Ambesajir; Atul Kaushik; Jeevan J Kaushik; Sham T Petros
Journal:  Saudi J Biol Sci       Date:  2012-08-17       Impact factor: 4.219

9.  Human AAT gene transfer to pig liver improved by using a perfusion isolated organ endovascular procedure.

Authors:  Luis Sendra; Daniel Pérez; Antonio Miguel; María José Herrero; Inmaculada Noguera; Ana Díaz; Domingo Barettino; Luis Martí-Bonmatí; Salvador F Aliño
Journal:  Eur Radiol       Date:  2015-04-25       Impact factor: 5.315

10.  Phenotypic correction of ornithine transcarbamylase deficiency using low dose helper-dependent adenoviral vectors.

Authors:  Nicola Brunetti-Pierri; Christian Clarke; Viraj Mane; Donna J Palmer; Brendan Lanpher; Qin Sun; William O'Brien; Brendan Lee
Journal:  J Gene Med       Date:  2008-08       Impact factor: 4.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.